In vivo 1H-MRS evaluation of malignant and benign breast diseases

Breast

Volumn 12, Issue 3, 2003, Pages 179-182

  Kim, Jong Ki ^a   Park, Sung Hwan ^a   Lee, Hyun Mee ^b   Lee, Young Hwan ^a   Sung, Nak Kwan ^a   Chung, Duck Soo ^a   Kim, Ok Dong ^a  

^a Catholic University of Daegu   (South Korea)

^b Yeungnam University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; BREAST DISEASE; BREAST FIBROADENOMA; BREAST HYPERPLASIA; CARCINOMA IN SITU; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; FIBROCYSTIC BREAST DISEASE; HUMAN; HUMAN TISSUE; IN VIVO STUDY; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SENSITIVITY ANALYSIS; BREAST TUMOR; CHEMISTRY; EVALUATION; FIBROADENOMA; HYPERPLASIA; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PAGET NIPPLE DISEASE; PATHOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHOLINE; DIAGNOSIS, DIFFERENTIAL; FEMALE; FIBROADENOMA; FIBROCYSTIC BREAST DISEASE; HUMANS; HYPERPLASIA; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0038617637     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9776(03)00012-2     Document Type: Article

References (12)

1. Negendank W. Studies of human tumors by MRS: a review. NMR Biomed 1992; 5: 303-324.
2. Kurhanewicz J, MacDonald J M, Vigneron D B, Konety B, Nelson S J, Narayan P, Hricak H. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. J Urol 1995; 45: 459-466.
3. Kim J K, Park S H. In vivo differential diagnosis between malignant and benign human diseases using localized PRESS proton magnetic resonance spectroscopy. In: Proceedings from the sixth scientific meeting and exhibition of ISMRM, Sidney, 1998; p. 941.
4. 1H MR spectroscopy. J Magn Reson Imag 1999; 10: 159-164.
5. Cecil K M, Schnall M D, Siegelman E S, Lenkinski R E. The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy. Breast Cancer Res Treat 2001; 68: 45-54.
6. Jagannathan N R, Kumar M, Seenu V, Coshic O, Dwivedi S N, Julka P K, Srivastava A, Rath G K. Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer 2001; 84: 1016-1022.
7. Roebuck J R, Cecil K M, Schnall M D, Lenkinski R E. Human breast lesions - characterization with proton MR spectroscopy. Radiology 1998; 209: 269-275.
8. Gribbestad I S, Fjφsne H E, Haugen O A. In vitro proton NMR spectroscopy of extracts from human breast tumor and non-involved breast tissue. Anticancer Res 1993; 13: 1973-1980.
9. 1H NMR spectroscopic characterization of perchloric acid extracts from breast carcinomas and non-involved breast tissue. NMR Biomed 1994; 7: 181-194.
10. Mackinnon W B, Barry P A, Malycha P L, Gillett D J, Russell P, Lean C L et al. Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. Radiology 1997; 204: 661-666.
11. Mountford C E, Somorjai R L, Malycha P, Gluch L, Lean C, Russell P, Barraclough B, Gillett D, Himmelreich U, Dolenko B, Nikulin A E, Smith I C. Diagnosis and prognosis of breast cancer by magnetic resonance spectroscopy of fine-needle aspirates analysed using a statistical classification strategy. Br J Surg 2001; 88: 1234-1240.
12. Sijens P E, Wijrdeman H K, Moerland M A, Bakker C J G, Vermiculen J W A, Luyten P R. Human breast cancer in vivo H-1 and P-31 MR spectroscopy at 1.5T. Radiology 1988;169: 615-620.